Compare WST & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | CRS |
|---|---|---|
| Founded | 1923 | 1910 |
| Country | United States | United States |
| Employees | 10800 | N/A |
| Industry | Medical/Dental Instruments | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8B | 29.8B |
| IPO Year | 2004 | 1994 |
| Metric | WST | CRS |
|---|---|---|
| Price | $365.55 | $592.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $325.86 | ★ $419.75 |
| AVG Volume (30 Days) | 674.9K | ★ 824.0K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.30% | 0.20% |
| EPS Growth | 1.49 | ★ 100.54 |
| EPS | 1.92 | ★ 7.29 |
| Revenue | ★ $2,886,900,000.00 | $2,157,700,000.00 |
| Revenue This Year | $6.76 | $9.21 |
| Revenue Next Year | $6.22 | $10.50 |
| P/E Ratio | $190.59 | ★ $81.99 |
| Revenue Growth | 1.95 | ★ 20.03 |
| 52 Week Low | $206.80 | $228.00 |
| 52 Week High | $367.66 | $624.50 |
| Indicator | WST | CRS |
|---|---|---|
| Relative Strength Index (RSI) | 78.53 | 68.88 |
| Support Level | $253.53 | $297.11 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 7.33 | 21.55 |
| MACD | 2.68 | -0.22 |
| Stochastic Oscillator | 95.80 | 61.44 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.